TopStocksTrader Newsletter

About the Substack

Welcome to our publication which offers investment ideas in today's dynamic markets. Our subscription rates are very low; offering the best value for the individual investor. With weekly 100% winners; you could earn back your cost in a single trade!

Free Subscription Benefits

  • Frequent Public Posts

Paid Subcription Benefits

  • Subscriber-only posts and Full Posts Archive
  • Post comments and join the community
  • Special Alerts for Hot Stocks, Crypto & Options

Paid Subscription Plans

  • $69.99 a year
  • $9.99 a month

About TopStocksTrader

Long time professional just trying to help people make sense of the markets, trends, crypto and trends. Not a financial advisor

Is this your Substack? Submit changes.

TopStocksTrader Newsletter's recommended Substacks

SmartReversalsโ€™ Trading Compass logo
SmartReversals

SmartReversalsโ€™ Trading Compass

I decode with technical analysis and price levels the SPX, Magnificent 7, ETFs, and other megacaps 3x per week. Daily updates and levels for SPX and expanded watchlist for founding members.

100+
paid subscribers
28K+
free subscribers
Block Scholes Research logo
Andrew Melville

Block Scholes Research

Crypto Market Research, discovering market-leading insights in crypto-asset derivatives, trusted by global financial institutions.

The Setup Factory logo
The Setup Factory

The Setup Factory

Welcome to TSF. โ€ข A 4x weekly swing trading publication โ€ข A private Discord community of 400+ traders โ€ข The Setup Factory Analytics Platformโ€” a proprietary thematic relative strength and stock screening platform thesetupfactory.com

100+
paid subscribers
4K+
free subscribers
The Market Dispatch logo
The Market Dispatch

The Market Dispatch

Monthly, data-driven insights on U.S. equities and macro trends โ€” clear, concise, and actionable.

1K+
free subscribers
The M&A Hunter logo
The M&A Hunter

The M&A Hunter

Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"

100+
paid subscribers
1K+
free subscribers